Other News To Note
Friday, January 4, 2013
Icon Bioscience Inc., of Sunnyvale, Calif., said melphalan intraocular injection, its investigational product for treating retinoblastoma, was granted orphan designation by the FDA.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.